Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives... Show more
Celanese, a global specialty materials and chemicals company, is navigating a demanding demand environment across its Engineered Materials and Acetyl Chain businesses. The upcoming third-quarter report will test whether recent cost actions and strategic shifts toward higher-margin applications are translating into improved results. In the prior quarter, Celanese delivered adjusted EPS of $2.45, exceeding estimates, but cautious guidance weighed on the stock. With management having lowered its third-quarter outlook, this report offers an important read on end-market demand, pricing power, and the company's progress toward deleveraging, making it a key checkpoint for investors tracking a potential earnings inflection.
Analysts expect Celanese to report third-quarter 2026 adjusted earnings per share of approximately $1.56 on revenue near $2.62 billion, according to consensus estimates. That would represent year-over-year EPS growth of roughly 16% and revenue growth of about 8% versus the $1.34 per share and $2.42 billion reported in the third quarter of 2025.
Company guidance is more conservative. Alongside its second-quarter release, Celanese projected third-quarter adjusted EPS of $1.35 to $1.75, a notable step down from the prior range of $2.00 to $2.40, and set adjusted EBIT guidance of $135 million to $175 million. This divergence means the market will be closely watching whether results land at the top or bottom of that range.
Historically, Celanese has beaten consensus EPS in five of its last eight quarters, including a $0.22 beat in the second quarter of 2026. However, revenue has been roughly in line or slightly below expectations in recent periods, underscoring the importance of margin execution and volume trends over headline sales.
Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is designed to help identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. For investors monitoring earnings events like Celanese's upcoming report, the AI Screener offers a streamlined way to surface actionable ideas across the chemicals and specialty materials sector.
Sentiment heading into Celanese's third-quarter report is cautious. The stock has trended lower since the company's August earnings release, when shares fell after management issued third-quarter guidance that disappointed investors despite a second-quarter EPS beat. The lowered outlook, combined with an elevated debt profile and persistent end-market softness in automotive and industrial applications, has kept pressure on the shares.
Key risk factors ahead of the report include any further deterioration in demand, pricing pressure across the Acetyl Chain, and updates on net debt, which management has targeted to reduce to roughly $9 billion by the end of 2027. A result at the upper end of guidance, paired with stabilizing volumes, could shift sentiment, while another downward revision would likely reinforce the stock's cautious tone.
Following the report, investors should watch management's commentary on full-year guidance and any update to the maintained 2026 adjusted EPS target of $6.00. The company has also signaled free cash flow of $700 million to $800 million for the year, and progress on this metric will be an important gauge of deleveraging capacity.
Demand signals across Celanese's Engineered Materials segment, which is expected to grow about 15% for the full year, remain a central focus. The company has emphasized a shift toward higher-margin niches such as data centers and medical devices, highlighting AI (artificial intelligence) servers as a meaningful content opportunity.
Finally, monitor cost trends, margin trajectory, and any updates on planned divestitures. With net debt projected near $10 billion by the end of 2026, successful execution of cost reductions and asset sales will be critical to the balance-sheet story and to investor confidence in the quarters ahead.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a producer of industrial chemicals
Industry ChemicalsMajorDiversified